Cargando…
Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings unde...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577904/ https://www.ncbi.nlm.nih.gov/pubmed/36253018 http://dx.doi.org/10.1136/bmjgh-2022-009801 |
_version_ | 1784811859544637440 |
---|---|
author | Hu, Huiyu Arzika, Ahmed Mamane Sie, Ali Abdou, Amza Maliki, Ramatou Mankara, Alio Karamba Outtara, Mamadou Bountogo, Mamadou Boudo, Valentin Yago-Wienne, Fanny Bamba, Issouf Knirsch, Charles Emerson, Paul Hooper, PJ Lebas, Elodie Brogdon, Jessica Nyatigo, Fanice Oldenburg, Catherine E Lietman, Thomas M O'Brien, Kieran S |
author_facet | Hu, Huiyu Arzika, Ahmed Mamane Sie, Ali Abdou, Amza Maliki, Ramatou Mankara, Alio Karamba Outtara, Mamadou Bountogo, Mamadou Boudo, Valentin Yago-Wienne, Fanny Bamba, Issouf Knirsch, Charles Emerson, Paul Hooper, PJ Lebas, Elodie Brogdon, Jessica Nyatigo, Fanice Oldenburg, Catherine E Lietman, Thomas M O'Brien, Kieran S |
author_sort | Hu, Huiyu |
collection | PubMed |
description | BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1–5 months old in studies of azithromycin distribution for child survival, but a simplified approach using age or height for all aged 1–11 months old could increase programme efficiency in real-world settings. METHODS: This secondary analysis used data from two cluster randomised trials of azithromycin distribution for child mortality in Niger and Burkina Faso. An exhaustive search algorithm was developed to determine the optimal dose for different age groups, using tolerance limits of 10–20 mg/kg for children 1–2 months old and 15–30 mg/kg for children 3–11 months old. Height-based dosing was evaluated against the existing trachoma dosing pole and with a similar exhaustive search. RESULTS: The optimal two-tiered age-based approach suggested a dose of 80 mg (2 mL) for children 1–2 months old and 160 mg (4 mL) for children 3–11 months old. Under this schedule, 89%–93% of children would have received doses within tolerance limits in both study populations. Accuracy was 93%–94% with a three-tiered approach, which resulted in doses of 80 mg (2 mL), 120 mg (3 mL) and 160 mg (4 mL) for children 1–2, 3–4 and 5–11 months old, respectively. For children 1–5 months old, the existing height pole would result in 70% of doses within tolerance limits. The optimisation identified height-based dosing options with 95% accuracy, although this would require changes to the existing dosing pole as well as additional training to measure infants lying flat. CONCLUSIONS: Overall, an age-based approach with two age tiers resulted in high accuracy while considering both concerns about overdosing in this young population and simplicity of field operations. |
format | Online Article Text |
id | pubmed-9577904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-95779042022-10-19 Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols Hu, Huiyu Arzika, Ahmed Mamane Sie, Ali Abdou, Amza Maliki, Ramatou Mankara, Alio Karamba Outtara, Mamadou Bountogo, Mamadou Boudo, Valentin Yago-Wienne, Fanny Bamba, Issouf Knirsch, Charles Emerson, Paul Hooper, PJ Lebas, Elodie Brogdon, Jessica Nyatigo, Fanice Oldenburg, Catherine E Lietman, Thomas M O'Brien, Kieran S BMJ Glob Health Original Research BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1–11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1–5 months old in studies of azithromycin distribution for child survival, but a simplified approach using age or height for all aged 1–11 months old could increase programme efficiency in real-world settings. METHODS: This secondary analysis used data from two cluster randomised trials of azithromycin distribution for child mortality in Niger and Burkina Faso. An exhaustive search algorithm was developed to determine the optimal dose for different age groups, using tolerance limits of 10–20 mg/kg for children 1–2 months old and 15–30 mg/kg for children 3–11 months old. Height-based dosing was evaluated against the existing trachoma dosing pole and with a similar exhaustive search. RESULTS: The optimal two-tiered age-based approach suggested a dose of 80 mg (2 mL) for children 1–2 months old and 160 mg (4 mL) for children 3–11 months old. Under this schedule, 89%–93% of children would have received doses within tolerance limits in both study populations. Accuracy was 93%–94% with a three-tiered approach, which resulted in doses of 80 mg (2 mL), 120 mg (3 mL) and 160 mg (4 mL) for children 1–2, 3–4 and 5–11 months old, respectively. For children 1–5 months old, the existing height pole would result in 70% of doses within tolerance limits. The optimisation identified height-based dosing options with 95% accuracy, although this would require changes to the existing dosing pole as well as additional training to measure infants lying flat. CONCLUSIONS: Overall, an age-based approach with two age tiers resulted in high accuracy while considering both concerns about overdosing in this young population and simplicity of field operations. BMJ Publishing Group 2022-10-17 /pmc/articles/PMC9577904/ /pubmed/36253018 http://dx.doi.org/10.1136/bmjgh-2022-009801 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Hu, Huiyu Arzika, Ahmed Mamane Sie, Ali Abdou, Amza Maliki, Ramatou Mankara, Alio Karamba Outtara, Mamadou Bountogo, Mamadou Boudo, Valentin Yago-Wienne, Fanny Bamba, Issouf Knirsch, Charles Emerson, Paul Hooper, PJ Lebas, Elodie Brogdon, Jessica Nyatigo, Fanice Oldenburg, Catherine E Lietman, Thomas M O'Brien, Kieran S Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title | Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title_full | Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title_fullStr | Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title_full_unstemmed | Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title_short | Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
title_sort | simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577904/ https://www.ncbi.nlm.nih.gov/pubmed/36253018 http://dx.doi.org/10.1136/bmjgh-2022-009801 |
work_keys_str_mv | AT huhuiyu simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT arzikaahmedmamane simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT sieali simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT abdouamza simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT malikiramatou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT mankaraaliokaramba simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT outtaramamadou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT bountogomamadou simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT boudovalentin simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT yagowiennefanny simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT bambaissouf simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT knirschcharles simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT emersonpaul simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT hooperpj simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT lebaselodie simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT brogdonjessica simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT nyatigofanice simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT oldenburgcatherinee simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT lietmanthomasm simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols AT obrienkierans simplifieddosingoforalazithromycinforchildren111monthsoldinchildsurvivalprogrammesagebasedandheightbaseddosingprotocols |